WASHINGTON D.C.: University scientists are celebrating a major breakthrough with a revolutionary new drug that could prevent the early stages of Alzheimer’s for thousands of people worldwide.
The university has filed a patent application and the drug will be progressing into clinical trials.
If it passes regulatory hurdles, the ultimate aim is to give the drug to people with mild symptoms of memory loss.
In laboratory tests, researchers showed how their drug reduces the number of these senile plaques, and the amount of brain inflammation and oxidative damage associated with Alzheimer’s disease…